Neuroprotective Efficacy of Postnatal Magnesium Sulphate in Term Infants With Birth Asphyxia
A Multicentre Double Blind Trial of the Neuroprotective Efficacy of Postnatal Magnesium Sulphate in Term/Near Term Infants With Moderate to Severe Birth Asphyxia
Sponsor: University of Health Sciences Lahore
This NA trial investigates Birth Asphyxia and is currently completed. University of Health Sciences Lahore leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
Status: Unknown → Completed
-
Mar 2025 — Oct 2025 [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Mar 2023 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Health Sciences Lahore
For direct contact, visit the study record on ClinicalTrials.gov .